Evotec SE (EVOTF) Financials

EVOTF Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 1.8 billion 1.0 billion
March 31, 2026 1.9 billion 1.1 billion
Dec. 31, 2025 2.1 billion 1.1 billion
Sept. 30, 2025 2.1 billion 1.1 billion

EVOTF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -133.3 million ?
March 31, 2026 -7.3 million ?
Dec. 31, 2025 56.5 million ?
Sept. 30, 2025 -103.0 million ?

EVOTF Net Income

No data available :(

EVOTF Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 530.6 million 472.1 million -
March 31, 2026 511.6 million 343.8 million -
Dec. 31, 2025 559.1 million 228.7 million 175.0 million
Sept. 30, 2025 278.4 million 455.0 million -

EVOTF Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 202.9 million
March 31, 2026 203.5 million
Dec. 31, 2025 208.3 million
Sept. 30, 2025 208.5 million

EVOTF Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 10.4 million 11.7 million 44.8 million -
March 31, 2026 4.8 million 11.6 million 50.4 million -
Dec. 31, 2025 18.2 million 11.5 million 52.0 million -
Sept. 30, 2025 23.7 million 10.2 million 49.7 million -

EVOTF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 163.5 million 165.3 million
March 31, 2026 180.2 million 182.0 million
Dec. 31, 2025 297.2 million 205.1 million
Sept. 30, 2025 192.3 million 192.4 million

EVOTF

Price: $3.32

52 week price:
3.33
8.36

Earnings Per Share: -1.26 USD

Exchange: PNK

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Market Capitalization: 1.2 billion

Links: